Letter to the editors on 'Clinical efficacy of lenvatinib for the treatment of radioiodine-refractory thyroid carcinoma: A systematic review and meta-analysis of clinical trials'.

We read the recent study "Clinical efficacy of lenvatinib for the treatment of radioiodine-refractory thyroid carcinoma: A systematic review and meta-analysis of clinical trials" by Zhipeng Yan, et al. for the evaluation of lenvatinib in the treatment of radioiodine-refractory thyroid carcinoma. This article is protected by copyright. All rights reserved.